2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS

or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MALAGU, Karine, DUGGAN, Heather Mary Ellen, LEROUX, Frederic Georges Marie, MENEAR, Keith, Allan, SMITH, Graeme, Cameron, Murray, MARTIN, Niall, Morrisson, Barr
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MALAGU, Karine
DUGGAN, Heather Mary Ellen
LEROUX, Frederic Georges Marie
MENEAR, Keith, Allan
SMITH, Graeme, Cameron, Murray
MARTIN, Niall, Morrisson, Barr
description or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2057156B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2057156B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2057156B13</originalsourceid><addsrcrecordid>eNrjZIg00vV1DfGI9PH1Dwrw8Pfx9HNVCIgM8nTx19UB0o5R_roKjn4uYDFfkCiUAVLn4hrkGeYY4hnmGqzgGKzgG-IfpODp5-Hp5AlkBfMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXACMDU3NDUzMnQ2MilAAAChQxrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS</title><source>esp@cenet</source><creator>MALAGU, Karine ; DUGGAN, Heather Mary Ellen ; LEROUX, Frederic Georges Marie ; MENEAR, Keith, Allan ; SMITH, Graeme, Cameron, Murray ; MARTIN, Niall, Morrisson, Barr</creator><creatorcontrib>MALAGU, Karine ; DUGGAN, Heather Mary Ellen ; LEROUX, Frederic Georges Marie ; MENEAR, Keith, Allan ; SMITH, Graeme, Cameron, Murray ; MARTIN, Niall, Morrisson, Barr</creatorcontrib><description>or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170201&amp;DB=EPODOC&amp;CC=EP&amp;NR=2057156B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170201&amp;DB=EPODOC&amp;CC=EP&amp;NR=2057156B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MALAGU, Karine</creatorcontrib><creatorcontrib>DUGGAN, Heather Mary Ellen</creatorcontrib><creatorcontrib>LEROUX, Frederic Georges Marie</creatorcontrib><creatorcontrib>MENEAR, Keith, Allan</creatorcontrib><creatorcontrib>SMITH, Graeme, Cameron, Murray</creatorcontrib><creatorcontrib>MARTIN, Niall, Morrisson, Barr</creatorcontrib><title>2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS</title><description>or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIg00vV1DfGI9PH1Dwrw8Pfx9HNVCIgM8nTx19UB0o5R_roKjn4uYDFfkCiUAVLn4hrkGeYY4hnmGqzgGKzgG-IfpODp5-Hp5AlkBfMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXACMDU3NDUzMnQ2MilAAAChQxrQ</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>MALAGU, Karine</creator><creator>DUGGAN, Heather Mary Ellen</creator><creator>LEROUX, Frederic Georges Marie</creator><creator>MENEAR, Keith, Allan</creator><creator>SMITH, Graeme, Cameron, Murray</creator><creator>MARTIN, Niall, Morrisson, Barr</creator><scope>EVB</scope></search><sort><creationdate>20170201</creationdate><title>2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS</title><author>MALAGU, Karine ; DUGGAN, Heather Mary Ellen ; LEROUX, Frederic Georges Marie ; MENEAR, Keith, Allan ; SMITH, Graeme, Cameron, Murray ; MARTIN, Niall, Morrisson, Barr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2057156B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MALAGU, Karine</creatorcontrib><creatorcontrib>DUGGAN, Heather Mary Ellen</creatorcontrib><creatorcontrib>LEROUX, Frederic Georges Marie</creatorcontrib><creatorcontrib>MENEAR, Keith, Allan</creatorcontrib><creatorcontrib>SMITH, Graeme, Cameron, Murray</creatorcontrib><creatorcontrib>MARTIN, Niall, Morrisson, Barr</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MALAGU, Karine</au><au>DUGGAN, Heather Mary Ellen</au><au>LEROUX, Frederic Georges Marie</au><au>MENEAR, Keith, Allan</au><au>SMITH, Graeme, Cameron, Murray</au><au>MARTIN, Niall, Morrisson, Barr</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS</title><date>2017-02-01</date><risdate>2017</risdate><abstract>or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2057156B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title 2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T18%3A41%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MALAGU,%20Karine&rft.date=2017-02-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2057156B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true